Fisher Asset Management
CMPX icon

Fisher Asset Management’s Compass Therapeutics CMPX Stock Holding History

Fisher Asset Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
1,391,890
+43,631
+3% +$129K ﹤0.01% 529
2026
Q1 		$7.13M Buy
+1,348,259
New +$7.78M ﹤0.01% 428

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fisher Asset Management's CMPX Position: Q2 2026 in Review

Fisher Asset Management increased its Compass Therapeutics (CMPX) stake by 3.2% in Q2 2026, buying an estimated $129K and bringing the position to 1,391,890 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #529.

Fisher Asset Management first reported a position in CMPX in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.13M in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Fisher Asset Management held 1,391,890 shares of Compass Therapeutics worth $3.05M as of Q2 2026.
  • Fisher Asset Management bought 43,631 Compass Therapeutics shares in Q2 2026, an estimated $129K.
  • Compass Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #529 holding.
  • Fisher Asset Management first reported a position in Compass Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Fisher Asset Management's Compass Therapeutics position peaked at $7.13M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.